FDA Drug Name Guidance Will Address Labeling and Packaging-Related Errors
Executive Summary
Medication errors related to labeling and packaging confusion will be addressed in an upcoming guidance on drug name confusion from FDA.
You may also be interested in...
Brand Names In 2008: Can Industry Pilot Its Way Out Of Trouble?
Industry may shoulder some of the burden of testing proprietary drug names this year under a pilot program included in the renewal of the Prescription Drug User Fee Act, but with that may come some clarity in a subjective field that so far has lacked detailed guidance from FDA
Brand Names In 2008: Can Industry Pilot Its Way Out Of Trouble?
Industry may shoulder some of the burden of testing proprietary drug names this year under a pilot program included in the renewal of the Prescription Drug User Fee Act, but with that may come some clarity in a subjective field that so far has lacked detailed guidance from FDA
CDER Deputy Galson Brings Risk Management Experience To FDA Surveillance
FDA Center for Drug Evaluation & Research Deputy Director Steven Galson, MD, has experience in public health risk assessment that will contribute to the center's revamping of its postmarketing surveillance program.